Atellica DCA Analyzer
Reimagine what’s possible at the point of care
Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.
Compact. Portable. Scalable. Customizable.
Building upon one of the industry’s most trusted technologies for diabetes testing, the Atellica DCA Analyzer puts fast, quality HbA1c and ACR results right at your fingertips. Experience the performance and precision you need to improve outcomes. Designed with the speed, standardization, and personalization you want to boost efficiencies and meet growing demand.
Leading the way in POC diabetes testing for more than 30 years.
The Atellica DCA Analyzer uses the same robust latex agglutination inhibition immunoassay as the DCA Vantage and DCA 2000+ analyzers.
Building upon one of the industry’s most trusted technologies for diabetes testing, our HbA1c immunoassay chemistry delivers reliable results, test after test.
Only 1μL capillary or venous whole blood
Small sample size reduces patient discomfort and likelihood of operator error.
Heparinized capillary
Enables extended sample hold time, mitigates risk of lost samples and need to retest patients.
Unaffected by sample hemolysis
Atellica® DCA HbA1c test can process hemolyzed samples and helps reduce pre-analytical errors caused by specimen collection.
Specificity to HbA1c can achieved with immunoassay
Unlike other methodologies, Siemens Healthineers immunoassay test was specifically designed to target only HbA1c.
Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.